Abstract Details

Title Immersive Connectivism Learning in Neuro-oncology: A Curriculum Innovation Initiative

Topic ��ɫ��, Research, and Methodology

Presentation(s) P7 - Poster Session 7 (11:45 AM-12:45 PM)

Poster/Presentation
Number 7-008

Objective We created an immersed collaborative learning curriculum in Neuro-Oncology delivered in an interactive retreat format for residents and evaluated its impact on skills, knowledge, and specialty choice.

Background Many neurology residents have limited exposure to neuro-oncology. Immersed collaborative learning encourages residents to explore uncommon specialties, learn core skills relevant to neurology, and supplement their education, while connecting with external mentors and resident peers.

Design/Methods A two-day immersive curriculum was designed employing multiple teaching formats, including “chalk talks”, case-based learning, mock tumor board, role play, small group discussion, and an escape room. Topics included brain tumor diagnosis and management, patient experience and communication, clinical trial design, research innovations, and career development. Course objectives were evaluated by pre-/post-design of resident reactions (Kirkpatrick Level 1), self-reported change in knowledge (Kirkpatrick Level 2). Open-ended comments were collected.

Results Nineteen residents from the US and Canada (PGY2=9, PGY3=10) participated. Surveys were completed by all participants. Four participants came from programs with no neuro-oncology faculty. 58% were >50% certain about a career in neuro-oncology before the program, and after, 93% were more inclined or equally confident about a neuro-oncology career. All residents reported that because of the experience they will be “better able to have difficult conversations with patients”, “can better take care of neuro-oncology patients”, “better understand brain tumors and their management” and “better understand the clinical practice of neuro-oncology.” All residents reported that the content was “just right” for their level. 64% reported increased interest in research post-program. Open-ended comments demonstrated the benefit of structured training on communication skills. Residents expressed appreciation for mentorship and networking.

Conclusions For neurological subspecialties not represented in all neurology programs, an immersive learning program gives residents exposure to rare subspecialities, the opportunity to learn communication skills, explore career opportunities, and build relationships outside of their program.

Authors/Disclosures
Alissa A. Thomas, MD, FAAN (University of Vermont Medical Center) PRESENTER	The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Lauryn Hemminger (Strong Memorial Hospital)	Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Justin T. Jordan, MD, MPH, FAAN (University of Texas Southwestern Medical Center)	Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Rajiv Magge, MD (Weill Cornell Medicine)	An immediate family member of Dr. Magge has received personal compensation for serving as an employee of Doximity. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Medplace. Dr. Magge has received personal compensation in the range of $5,000-$9,999 for serving as a Founding Medical Content Contributor with Roon.
Kathryn S. Nevel, MD (Indiana University School of Medicine)	Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
Lauren Schaff, MD, FAAN (Memorial Sloan Kettering Cancer Center)	Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG, plc. The institution of Dr. Schaff has received research support from BTG, plc. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Ono.
Roy E. Strowd III, MD, FAAN (Wake Forest School Of Medicine)	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Nimish A. Mohile, MD, FAAN	The institution of Dr. Mohile has received research support from Novocure.

��ɫ����

��ɫ����

��ɫ��

��ɫ��